Healixa's Subsidiary PurelyRx Launches Its New Satellite Location
09 Novembre 2021 - 3:55PM
InvestorsHub NewsWire
Manhattan, NY -- November 9,
2021 -- InvestorsHub NewsWire -- Healixa, Inc. (OTC:
EMOR) (“Healixa”, or the “Company”), a technology company
focusing on building and acquiring innovative and disruptive
technologies in the health-tech, clean water, and green-tech
industries, announces it’s subsidiary PurelyRx held a soft launch
for PurelyRx’s new satellite location in Coppell, Texas. This
announcement is on the heels of PurelyRx launch of its digital
pharmacy logistics administrative
portal.
PurelyRx launched its new
satellite location in Coppell, Texas. This location was
strategically chosen because of Coppell’s close proximity to the
Dallas-Fort Worth metroplex, which has massive business
and technology growth occurring throughout the area, including an
Amazon distribution center, a centrally located UPS, and several
other fortune 500 companies such as Nokia, Brinks, 7-Eleven. This
PurelyRx location will be piloting PurelyRx’s recently announced
administrative pharmacy logistics application throughout the
community both residentially and
commercially.
Purely RX seeks to deliver a
true value proposition, by its deep understanding of the market
segment and appeal of a digital pharmacy. A Digital Pharmacy is the
convergence of the digital revolution with pharmacy operations.
It’s how digital tools and technologies are used to improve
pharmacy business, practice, physician communication, continuity of
care and patient care. Ian Parker, CEO of Healixa, said “As complex
as the pharmacy industry is, the patient experience needs to be
simple. The fact that our customers are online more than they
actually sleep means we need to be fully engaged with them
digitally with our simple to use, on-demand PurelyRx
platform.”
PurelyRx has been executing on
the organization’s go to market strategy in carefully implemented
steps since early 2021. The Company has strategically purchased
several assets, that are integral business modules, and has
implemented technology platforms, which have synergistically built
a solid foundation for its health tech portfolio. In early
2021 the Company purchased PurelyRx Central; a cash pay
pharmacy. In Q2 of 2021 the Company acquired PurelyRx North,
a pharmacy with pre-existing insurance and manufacturing
contracts. In Q3 of 2021, the Company launched the PurelyRx
MVP digital pharmacy logistics application. The Company has
validated its proof of concept by testing it with a nationally
recognized global rideshare logistics and technology
organization. All four go to market steps are critical
pillars to building PurelyRx’s infracture and future
profitability.
PurelyRx joined the digital
pharmacy revolution in 2021 by focusing on a full engagement with
physicians, pharmacists, and patients brought together through an
omnichannel conversation. This multifaceted conversation provides
the entire chain of care with the ability to better track and
manage healthcare data points. Purely Rx’s call to action was
simple: Consumers want repeat prescriptions to be ordered quicker
and easier, the ability to talk to a pharmacist about their
medicine right from their smartphone device, and the convenience of
having their medication delivered to whatever location they
choose.
The digital world has altered
how consumers behave and access health services. These changes have
created a revolutionary space for PurelyRx to provide digitally
adaptive services nationally to local pharmacies. Advanced
analytics, sensors, and the automation of complex decisions can
deliver a step change in the efficiency, speed, quality, and
responsiveness of the pharmaceutical industry. To thrive in a
digital world, pharma companies will need to deploy next-generation
technologies to streamline their business processes. PurelyRx is
well equipped to provide authentic solutions and
partnerships.
Healixa’s technology portfolio
now address two major challenges for truly sustainable communities:
1. Sustainable clean potable water (Atmospheric Water Harvesting®) and; 2. Digital
access to affordable prescription therapies available
on-demand.
About
Healixa Inc.
Healixa is a
technology company focusing on building and acquiring innovative
and disruptive technologies in the health-tech, clean water
generation and green-tech industries. Healixa embraces innovation
by combining its intellectual properties, patents, strategic
collaborations, and partnerships to create a “LaunchPad” of
disruptive sustainable products.
Forward-looking Statements
Certain
statements contained in this press release may constitute
forward-looking statements. For example, forward-looking statements
are used when discussing our expected research and development
programs, and more. These forward-looking statements are based only
on current expectations of management and are subject to
significant risks and uncertainties that could cause actual results
to differ materially from those described in the forward-looking
statements, including but not limited to the risks and
uncertainties related to the progress, timing, cost, and results of
Partnerships and product development programs; difficulties or
delays in obtaining regulatory approval or patent protection; and
competition from other companies. Except as otherwise required by
law, Healixa Inc., f.k.a. Emerald Organic Products, Inc.,
undertakes no obligation to publicly release any revisions to these
forward-looking statements to reflect events or circumstances after
the date hereof or to reflect the occurrence of unanticipated
events.
Healixa Inc
Contact
Bret
Hedges
SVP Global
Relations
1-833-432-5492
invest@healixa.com
Healixa Inc
Contact
Kealy
Altman
VP of Marketing,
Advertising & Social Media
1-561-2512966+
kealy@healixa.com
Investor
Relations Contact
Skyline Corporate
Communications Group, LLC
Scott Powell,
President & CEO
One Rockefeller
Plaza, 11th Floor
New York, NY
10020
Office: (646)
893-5835
Grafico Azioni Healixa (PK) (USOTC:EMOR)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni Healixa (PK) (USOTC:EMOR)
Storico
Da Gen 2024 a Gen 2025